Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2017, Article ID 3689827, 5 pages
https://doi.org/10.1155/2017/3689827
Research Article

Serum Alanine Aminotransferase Levels within Normal Range Have Different Associations with Augmentation Index and Other Cardiometabolic Risk Factors in Nondrinkers and Drinkers: A Chinese Community-Based Analysis

1Department of Geriatric Cardiology, Chinese People’s Liberation Army General Hospital, Beijing 100853, China
2Department of Cardiology and Hainan Branch, Chinese People’s Liberation Army General Hospital, Beijing 100853, China
3Department of Nephrology and Hainan Branch, Chinese People’s Liberation Army General Hospital, Beijing 100853, China

Correspondence should be addressed to Leiming Luo; moc.anis@miell and Ping Ye; moc.621@103ics

Received 26 December 2016; Revised 9 March 2017; Accepted 19 March 2017; Published 9 May 2017

Academic Editor: Kazuhiko Uchiyama

Copyright © 2017 Shihui Fu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Y. Oh, Y. K. Cho, M. S. Kang et al., “The association between increased alanine aminotransferase activity and metabolic factors in nonalcoholic fatty liver disease,” Metabolism, vol. 55, no. 12, pp. 1604–1609, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. C. H. Chen, M. H. Huang, J. C. Yang et al., “Prevalence and etiology of elevated serum alanine aminotransferase level in an adult population in Taiwan,” Journal of Gastroenterology and Hepatology, vol. 22, no. 9, pp. 1482–1489, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. M. Gholam, L. Flancbaum, J. T. Machan, D. A. Charney, and D. P. Kotler, “Nonalcoholic fatty liver disease in severely obese subjects,” The American Journal of Gastroenterology, vol. 102, no. 2, pp. 399–408, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. S. Y. Choi, D. Kim, J. H. Kang, M. J. Park, and H. S. Lee, “Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis,” The Korean Journal of Hepatology, vol. 14, no. 1, pp. 77–88, 2008. View at Publisher · View at Google Scholar
  5. A. L. Fracanzani, L. Valenti, E. Bugianesi et al., “Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes,” Hepatology, vol. 48, no. 3, pp. 792–798, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. H. C. Kim, C. M. Nam, S. H. Jee, K. H. Han, D. K. Oh, and I. Suh, “Normal serum aminotransferase concentration and risk of mortality from liver diseases: prospective cohort study,” BMJ, vol. 328, no. 7446, p. 983, 2004. View at Publisher · View at Google Scholar
  7. G. N. Ioannou, E. J. Boyko, and S. P. Lee, “The prevalence and predictors of elevated serum aminotransferase activity in the United States in 1999-2002,” The American Journal of Gastroenterology, vol. 101, no. 1, pp. 76–82, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. A. Lonardo, C. Carani, N. Carulli, and P. Loria, “‘Endocrine NAFLD’ a hormonocentric perspective of nonalcoholic fatty liver disease pathogenesis,” Journal of Hepatology, vol. 44, no. 6, pp. 1196–1207, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. J. D. Browning, L. S. Szczepaniak, R. Dobbins et al., “Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity,” Hepatology, vol. 40, no. 6, pp. 1387–1395, 2004. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Liao and J. Farmer, “Arterial stiffness as a risk factor for coronary artery disease,” Current Atherosclerosis Reports, vol. 16, no. 2, p. 387, 2014. View at Publisher · View at Google Scholar · View at Scopus
  11. K. Takazawa, “Augmentation index in heart disease,” American Journal of Hypertension, vol. 18, no. 1, part 2, pp. 15S–18S, 2005. View at Publisher · View at Google Scholar · View at Scopus
  12. J. Nürnberger, A. Keflioglu-Scheiber, A. M. Opazo Saez, R. R. Wenzel, T. Philipp, and R. F. Schäfers, “Augmentation index is associated with cardiovascular risk,” Journal of Hypertension, vol. 20, no. 12, pp. 2407–2414, 2002. View at Publisher · View at Google Scholar
  13. M. M. Kaplan, “Alanine aminotransferase levels: what’s normal?” Annals of Internal Medicine, vol. 137, no. 1, pp. 49–51, 2002. View at Publisher · View at Google Scholar
  14. S. H. Yang, K. F. Dou, and W. J. Song, “Prevalence of diabetes among men and women in China,” The New England Journal of Medicine, vol. 362, no. 25, pp. 2425–2426, 2010. View at Google Scholar
  15. P. Deurenberg, M. Deurenberg-Yap, and S. Guricci, “Asians are different from Caucasians and from each other in their body mass index/body fat per cent relationship,” Obesity Reviews, vol. 3, no. 3, pp. 141–146, 2002. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Westerbacka, A. Corner, M. Tiikkainen et al., “Women and men have similar amounts of liver and intra-abdominal fat, despite more subcutaneous fat in women: implications for sex differences in markers of cardiovascular risk,” Diabetologia, vol. 47, no. 8, pp. 1360–1369, 2004. View at Publisher · View at Google Scholar · View at Scopus